We have a significant presence in more than 100 countries with a growing reputation for excellence in emerging markets such as China, Mexico, Brazil and Russia.
We have 57,200 employees worldwide, 31% are in the Americas, 46% in Europe, Middle East and Africa and 23% in Asia-Pacific.
Around 11,300 people work in our R&D organisation and we have 14 principal R&D centres in eight countries.
We have 9,600 employees at 23 Supply and Manufacturing sites in 16 countries across the world. We’re not exaggerating when we proudly claim that our manufacturing site in North Ryde, Sydney is one of the best in the world. We’re committed to high-tech manufacturing in Australia and as one of the largest exporters of medicines we contribute significantly to the wider success of the Australian economy.
For further information about AstraZeneca global please click here.